POMBILITI
Analogs of POMBILITI
Find cheaper analogs and generic equivalents for POMBILITI.
Active Ingredient: CIPAGLUCOSIDASE ALFA
Product Overview
About POMBILITI
POMBILITI is a prescription medication containing the active ingredient CIPAGLUCOSIDASE ALFA, used to treat Pompe disease, a rare genetic disorder caused by the deficiency of acid alpha-glucosidase (GAA) enzyme. This enzyme plays a crucial role in breaking down glycogen in the body.
Key Benefits & Uses
- Treatment of Pompe disease, including infantile-onset, late-onset, and non-classic forms
- Reduction of glycogen accumulation in muscles, thereby alleviating symptoms and slowing disease progression
- Improvement in muscle strength and function, enabling patients to perform daily activities with greater ease
Active Ingredient & Action
CIPAGLUCOSIDASE ALFA is a recombinant human acid alpha-glucosidase enzyme that replaces the deficient enzyme in Pompe disease patients. It works by breaking down glycogen into glucose, which is then absorbed and utilized by the body for energy production. This helps to reduce glycogen accumulation in muscles, thereby alleviating symptoms and slowing disease progression.
Important Notes
POMBILITI is available by prescription only and should be used under the guidance of a qualified healthcare professional. Patients with Pompe disease should follow a strict treatment regimen, including regular infusions of POMBILITI, to achieve optimal results. Common side effects may include hypersensitivity reactions, infusion site reactions, and increased liver enzymes. Patients should report any adverse effects to their healthcare provider promptly.
Visitor ratings
Help others by rating how useful this product page is.
No ratings yet — be the first.